CN Patent

CN113286793B — 吡咯并吡嗪和吡啶并三嗪类流感病毒复制抑制剂

Assigned to Co Crystallization Pharmaceutical Co · Expires 2024-04-05 · 2y expired

What this patent protects

本文提供可抑制流感病毒复制、减少流感病毒量和/或治疗流感的化合物。(I)

USPTO Abstract

本文提供可抑制流感病毒复制、减少流感病毒量和/或治疗流感的化合物。(I)

Drugs covered by this patent

Patent Metadata

Patent number
CN113286793B
Jurisdiction
CN
Classification
—
Expires
2024-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Co Crystallization Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.